With September on its way in just a week, many streaming services have started informing subscribers (and potential new users) about all of the new titles set to join their lineups in the coming month ...

Prime Video had a busy summer, releasing hit shows like Countdown, The Summer I Turned Pretty season 3 and We Were Liars, as well as popular original movies like The Pickup with Eddie Murphy. While ...

YouTube TV’s millions of subscribers could lose Fox News, FS1, local Fox TV stations and more as soon as this Wednesday if the Google-owned video service can’t reach a deal with Fox Corp. The current ...

Griff Griffin is a Newsweek pop culture writer based in London. His focus is reporting on movies, streaming, and everything happening in the world of entertainment. He has in-depth knowledge of cinema ...

After a relatively quiet summer TV schedule, fall is kicking off the way it should: with a bunch of new and returning shows. Coming back this September are beloved favorites like the second half of ...

EXCLUSIVE: One of the more polarizing court cases in recent memory is about to get the Hollywood treatment. Sources tell Deadline that Prime Video and Warner Bros Television are in development on a ...

More for You Comedian’s arrest over social media posts sparks warning for Americans Ray Dalio says ‘most people are silent’ because they’re afraid to talk about what’s really happening with the U.S.

COLUMBUS, Ohio (WCMH) — New video from Grove City police shows a chase Saturday that ended in a deadly crash. Police said they were originally investigating an alleged theft involving two suspects.

Actress Elizabeth Banks, a Massachusetts native, will reportedly star as Karen Read in an upcoming series about the murder trial. Both Deadline and Variety reported Wednesday that Banks will star as ...

“Story Kitchen has always believed that ‘Life is Strange’ deserved to be more than just a game—it’s a cultural touchstone,” said Story Kitchen’s Johnson and Goldberg. “After a decade-long journey, ...

The development of new drugs continues to generate bullish interest from investors. Most of these companies are small, leaving their shares subject to explosive moves. Despite their big rallies, all ...